EMPLIPHARM

Safer treatments

Empli04

Empli04 is an innovative pharmaceutical product development project aimed at improving the patients potential side effects from of opioid use disorder (OUD) management. Through a multidisciplinary approach, we are dedicated to developing a novel formulation with a focus on efficacy and safety with less potential long term side effects.

Empli05

Emplicure aims to contribute in changing smoking habits for millions of people to live longer healthier lives and decrease the incidence of lung cancer by offering nicotine pouches as a nicotine replacement therapy for  smoking cessation.

 

Our interdisciplinary team of scientists, engineers, and designers is dedicated to creating a revolutionary smoking cessation medicine. Drawing inspiration from the latest advancements in oral nicotine delivery and user-centered design principles, we are developing a discreet, product to support individuals in overcoming smoking. Clinical trials and research studies are underway to evaluate the efficacy, safety, and usability of the product. We aspire to work with leading experts in the field to develop the best smoking cessation product. Our project’s success will be measured by its ability to help individuals quit smoking, reduce tobacco-related harm, and improve overall health outcomes.

Do you want to know more?